Skip to main content
Published Online:https://doi.org/10.3928/1081597X-20121011-01Cited by:155

Abstract

PURPOSE:

To study the progression rate of keratoconus and assess the clinical outcome of corneal collagen cross-linking (CXL) with riboflavin and ultraviolet A light in children and adolescent patients up to 3 years after treatment.

METHODS:

Fifty-nine eyes from 42 children and adolescents (aged 9 to 19 years) with confirmed keratoconus were included in this retrospective interventional cohort study. Refraction, slit-lamp examination, Placido-based corneal topography, and Scheimpflug imaging were performed bilaterally in all patients preoperatively and at 6 and 12 months postoperatively. Maximal keratometry readings (Kmax), corrected distance visual acuity (CDVA), corneal thickness, and the keratoconus index (KI) were analyzed. Follow-up was up to 36 months (mean follow-up: 26.3 months [range: 12 to 36 months]).

RESULTS:

Fifty-two of the 59 eyes enrolled in this study showed progression, corresponding to a progression rate of 88%. Forty-six eyes were treated by CXL. Maximal keratometry, CDVA, and KI showed significant changes over the follow-up period. However, significant Kmax reduction observed up to 24 months after CXL lost significance at 36 months.

CONCLUSIONS:

Cross-linking seems to be safe in children and adolescents. Progression of keratoconus occurred in 88%. We propose that awaiting documentation of progression is not mandatory and CXL in children and adolescents should be performed as soon as the diagnosis has been made. However, the effect of arrest of disease progression might not be as long-lasting as in adults and longer follow-up is needed to verify this trend.

  • 1.Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998; 66(1):97–103.10.1006/exer.1997.0410

    Crossref MedlineGoogle Scholar
  • 2.Coskunseven E, Jankov MR, Hafezi F. Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus. J Refract Surg. 2009; 25(4):371–376.10.3928/1081597X-20090401-02

    LinkGoogle Scholar
  • 3.Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE. Collagen cross-linking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg. 2008; 34(5):796–801.10.1016/j.jcrs.2007.12.039

    Crossref MedlineGoogle Scholar
  • 4.Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135(5):620–627.10.1016/S0002-9394(02)02220-1

    Crossref MedlineGoogle Scholar
  • 5.Ehlers N, Hjortdal J, Nielsen K, Sondergaard A. Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea. J Refract Surg. 2009; 25(9):S803–S806.10.3928/1081597X-20090813-08

    LinkGoogle Scholar
  • 6.Gatzioufas Z, Seitz B. Riboflavin-UVA treatment for nonhealing ulcers of the cornea. J Refract Surg. 2010; 26(5):312.

    LinkGoogle Scholar
  • 7.Hafezi F, Dejica P, Majo F. Modified corneal collagen crosslinking reduces corneal oedema and diurnal visual fluctuations in Fuchs dystrophy. Br J Ophthalmol. 2010; 94(5):660–661.10.1136/bjo.2009.162479

    Crossref MedlineGoogle Scholar
  • 8.Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2007; 33(12):2035–2040.10.1016/j.jcrs.2007.07.028

    Crossref MedlineGoogle Scholar
  • 9.Hafezi F, Mrochen M, Iseli HP, Seiler T. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J Cataract Refract Surg. 2009; 35(4):621–624.10.1016/j.jcrs.2008.10.060

    Crossref MedlineGoogle Scholar
  • 10.Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008; 27(5):590–594.10.1097/ICO.0b013e318169d698

    Crossref MedlineGoogle Scholar
  • 11.Martins SA, Combs JC, Noguera G, et al.Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008; 49(8):3402–3408.10.1167/iovs.07-1592

    Crossref MedlineGoogle Scholar
  • 12.Moren H, Malmsjo M, Mortensen J, Ohrstrom A. Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea. 2010; 29(1):102–104.10.1097/ICO.0b013e31819c4e43

    Crossref MedlineGoogle Scholar
  • 13.Schrier A, Greebel G, Attia H, Trokel S, Smith EF. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg. 2009; 25(9):S799–S802.10.3928/1081597X-20090813-07

    LinkGoogle Scholar
  • 14.Coskunseven E, Jankov MR, Hafezi F, Atun S, Arslan E, Kymionis GD. Effect of treatment sequence in combined intrastromal corneal rings and corneal collagen crosslinking for keratoconus. J Cataract Refract Surg. 2009; 35(12):2084–2091.10.1016/j.jcrs.2009.07.008

    Crossref MedlineGoogle Scholar
  • 15.Kanellopoulos AJ, Binder PS. Collagen cross-linking (CCL) with sequential topography-guided PRK: a temporizing alternative for keratoconus to penetrating keratoplasty. Cornea. 2007; 26(7):891–895.10.1097/ICO.0b013e318074e424

    Crossref MedlineGoogle Scholar
  • 16.Olivares Jimenez JL, Guerrero Jurado JC, Bermudez Rodriguez FJ, Serrano Laborda D. Keratoconus: age of onset and natural history. Optom Vis Sci. 1997; 74(3):147–151.10.1097/00006324-199703000-00025

    Crossref MedlineGoogle Scholar
  • 17.Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998; 42(4):297–319.10.1016/S0039-6257(97)00119-7

    Crossref MedlineGoogle Scholar
  • 18.Office of the United Nations High Commissioner of Human Rights. Convention on the rights of the child. United Nations Human Rights Web site. http://www2.ohchr.org/english/law/crc.htm#part1. Accessed October 10, 2012.

    Google Scholar
  • 19.The state of the world’s children 2011–adolescence: an age of opportunity. UNICEF Web site. http://www.uis.unesco.org/Library/Documents/state-world-children-adolescence-age-opportunity-education-2011-en.pdf. Accessed October 10, 2012.

    Google Scholar
  • 20.Alio JL, Shabayek MH. Corneal higher order aberrations: a method to grade keratoconus. J Refract Surg. 2006; 22(6):539–545.

    LinkGoogle Scholar
  • 21.Koller T, Iseli HP, Hafezi F, Vinciguerra P, Seiler T. Scheimpflug imaging of corneas after collagen cross-linking. Cornea. 2009; 28(5):510–515.10.1097/ICO.0b013e3181915943

    Crossref MedlineGoogle Scholar
  • 22.Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea. 2006; 25(9):1057–1059.10.1097/01.ico.0000225720.38748.58

    Crossref MedlineGoogle Scholar
  • 23.Dunn OJ. Multiple comparisons using rank sums. Technometrics (American Statistical Association). 1964; 6(3):241–252.

    Google Scholar
  • 24.Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009; 35(8):1358–1362.10.1016/j.jcrs.2009.03.035

    Crossref MedlineGoogle Scholar
  • 25.Caporossi A, Mazzotta C, Baiocchi S, Caporossi T, Denaro R, Balestrazzi A. Riboflavin-UVA-induced corneal collagen cross-linking in pediatric patients. Cornea. 2012; 31(3):227–231.10.1097/ICO.0b013e31822159f6

    Crossref MedlineGoogle Scholar
  • 26.Vinciguerra P, Albe E, Frueh BE, Trazza S, Epstein D. Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus. Am J Ophthalmol. 2012; 154(3):520–526.10.1016/j.ajo.2012.03.020

    Crossref MedlineGoogle Scholar
  • 27.Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T. Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg. 2006; 32(5):837–845.10.1016/j.jcrs.2006.01.091

    Crossref MedlineGoogle Scholar
  • 28.Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg. 2009; 25(9):S824–S828.10.3928/1081597X-20090813-12

    LinkGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×